Clinical Trials Directory

Trials / Sponsors / DermBiont, Inc.

DermBiont, Inc.

Industry · 13 registered clinical trials3 currently recruiting.

StatusTrialPhaseStarted
RecruitingRandomized Study Using SM-030 Gel for Adults With Melasma
Melasma
Phase 22024-06-27
RecruitingA Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratoses and Non-Mela
Non-Melanoma Skin Cancers
Phase 22024-03-25
Active Not RecruitingA Trial to Study the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Dermatosis Papulosa Nigra (DPN)
Dermatosis Papulosa Nigra
Phase 22023-11-07
RecruitingA Trial to Evaluate the Safety and Efficacy of SM-020 Gel 1.0% in Subjects With Seborrheic Keratosis
Seborrheic Keratosis
Phase 22023-11-06
SuspendedA Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Onyc
Onychomycosis
Phase 22023-11-01
UnknownA Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tine
Tinea Pedis
Phase 22022-09-08
CompletedRandomized and Open Label Study for Safety and Efficacy of DBI-102 vs. Vehicle vs. Hydroquinone on Skin Pigmen
Hyperpigmentation
Phase 22022-08-18
UnknownAdaptive Design Study for Safety and Efficacy of Treatment Regimens With SM-020 in Subjects With Seborrheic Ke
Seborrheic Keratosis
Phase 22021-10-19
TerminatedStudy the Safety and Efficacy of DBI-001 Gel Versus Aqueous Gel
Atopic Dermatitis
Phase 22021-10-06
CompletedA Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor
Tinea Versicolor
Phase 22021-03-16
TerminatedA Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis
Interdigital Tinea Pedis
Phase 22019-09-12
TerminatedObserver-Blinded Dose Escalating, Single Dose to Study Safety and Antimicrobial Efficacy of Gel vs. Placebo
Atopic Dermatitis
Phase 22019-05-20
CompletedA Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis
Tinea Pedis
Phase 22019-02-19